The Missing Piece in Employee Cancer Benefits
When it comes to employee benefits programs, cancer detection and care are evolving.
Cancer Benefits Landscape Overview
Sign up for more information about the Galleri test
- Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence — SEER 18 Regs Research Data. Nov 2018 Sub. Includes persons aged 50 – 79 diagnosed 2006 – 2015. “Early/Localized” includes invasive localized tumors that have not spread beyond organ of origin. “Late/Metastasized” includes invasive cancers that have metastasized beyond the organ of origin to other parts of the body.
- Noone AM, Howlader N, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975 – 2015, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER website April 2018.
- Henley SJ, et al. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer. 2020;126(10):2225 – 2249. doi: 10.1002/cncr.32802.
- Screening includes methods recommended by United States Preventative Task Force (USPSTF) A, B and C rating which includes breast, colon, cervical, prostate, and lung. https://www.uspreventiveservicestaskforce.org/
- Other cancer screening tests are available but may not be routinely recommended as standard of care for all patients.
- For patients at high risk of lung cancer.